Skip to main content
Erschienen in: Dysphagia 3/2023

12.08.2022 | Review

Esophageal Dysfunction in Post-lung Transplant: An Enigma

verfasst von: Aditya V. Jadcherla, Kevin Litzenberg, Gokulakrishnan Balasubramanian

Erschienen in: Dysphagia | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

The prevalence of lung transplants has increased over the years, albeit with a low survival rate amongst all solid organ transplants, including liver and heart transplantation. Microaspiration is one of the primary mechanisms that has been implicated in the pathogenesis of lung injury following lung transplants. Of late, esophageal dysfunction such as gastroesophageal reflux and esophageal hypercontractility is often noted post-lung transplant. However, reflux is associated with chronic allograft lung injury such as bronchiolitis obliterans syndrome, which is one of the predictors for long-term survival in this specialized population. Its role in acute lung injury post-lung transplant is still being explored. This review critically examines the salient points which provide the current understanding of the characteristics, pathophysiology, and implications of esophageal dysfunction following lung transplant.
Literatur
2.
Zurück zum Zitat Chambers DC, Yusen RD, Cherikh WS, Goldfarb SB, Kucheryavaya AY, Khusch K, Levvey BJ, Lund LH, Meiser B, Rossano JW, Stehlik J. Transplantation ISfHaL: the registry of the international society for heart and lung transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant. 2017;36:1047–59.PubMedCrossRef Chambers DC, Yusen RD, Cherikh WS, Goldfarb SB, Kucheryavaya AY, Khusch K, Levvey BJ, Lund LH, Meiser B, Rossano JW, Stehlik J. Transplantation ISfHaL: the registry of the international society for heart and lung transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant. 2017;36:1047–59.PubMedCrossRef
3.
4.
Zurück zum Zitat Girgis RE, Tu I, Berry GJ, Reichenspurner H, Valentine VG, Conte JV, Ting A, Johnstone I, Miller J, Robbins RC, Reitz BA, Theodore J. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant. 1996;15:1200–8.PubMed Girgis RE, Tu I, Berry GJ, Reichenspurner H, Valentine VG, Conte JV, Ting A, Johnstone I, Miller J, Robbins RC, Reitz BA, Theodore J. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant. 1996;15:1200–8.PubMed
6.
Zurück zum Zitat Chan WW, Ahuja N, Fisichella PM, Gavini S, Rangan V, Vela MF. Extraesophageal syndrome of gastroesophageal reflux: relationships with lung disease and transplantation outcome. Ann N Y Acad Sci. 2020;1482:95–105.PubMedCrossRef Chan WW, Ahuja N, Fisichella PM, Gavini S, Rangan V, Vela MF. Extraesophageal syndrome of gastroesophageal reflux: relationships with lung disease and transplantation outcome. Ann N Y Acad Sci. 2020;1482:95–105.PubMedCrossRef
7.
Zurück zum Zitat Chan M, Polacek K, Keller B, Nunley D, Howsware M, Burcham P, Balasubramanian G. Esophageal dysfunction is prevalent following lung transplantation. Gastroenterology. 2020;158(6):S-1107.CrossRef Chan M, Polacek K, Keller B, Nunley D, Howsware M, Burcham P, Balasubramanian G. Esophageal dysfunction is prevalent following lung transplantation. Gastroenterology. 2020;158(6):S-1107.CrossRef
8.
Zurück zum Zitat Masuda T, Mittal SK, Kovács B, Smith MA, Walia R, Huang JL, Bremner RM. Foregut function before and after lung transplant. J Thorac Cardiovasc Surg. 2019;158:619–29.PubMedCrossRef Masuda T, Mittal SK, Kovács B, Smith MA, Walia R, Huang JL, Bremner RM. Foregut function before and after lung transplant. J Thorac Cardiovasc Surg. 2019;158:619–29.PubMedCrossRef
9.
Zurück zum Zitat Cangemi DJ, Flanagan R, Bailey A, Staller K, Kuo B. Jackhammer esophagus after lung transplantation: results of a retrospective multicenter study. J Clin Gastroenterol. 2020;54:322–6.PubMedCrossRef Cangemi DJ, Flanagan R, Bailey A, Staller K, Kuo B. Jackhammer esophagus after lung transplantation: results of a retrospective multicenter study. J Clin Gastroenterol. 2020;54:322–6.PubMedCrossRef
10.
Zurück zum Zitat Young LR, Hadjiliadis D, Davis RD, Palmer SM. Lung transplantation exacerbates gastroesophageal reflux disease. Chest. 2003;124:1689–93.PubMedCrossRef Young LR, Hadjiliadis D, Davis RD, Palmer SM. Lung transplantation exacerbates gastroesophageal reflux disease. Chest. 2003;124:1689–93.PubMedCrossRef
11.
Zurück zum Zitat Hadjiliadis D, Duane Davis R, Steele MP, Messier RH, Lau CL, Eubanks SS, Palmer SM. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant. 2003;17:363–8.PubMedCrossRef Hadjiliadis D, Duane Davis R, Steele MP, Messier RH, Lau CL, Eubanks SS, Palmer SM. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant. 2003;17:363–8.PubMedCrossRef
12.
Zurück zum Zitat Posner S, Finn RT, Shimpi RA, Wood RK, Fisher D, Hartwig MG, Klapper J, Reynolds J, Niedzwiecki D, Parish A, Leiman DA. Esophageal contractility increases and gastroesophageal reflux does not worsen after lung transplantation. Dis Esophagus. 2019;32:1–8.PubMedCrossRef Posner S, Finn RT, Shimpi RA, Wood RK, Fisher D, Hartwig MG, Klapper J, Reynolds J, Niedzwiecki D, Parish A, Leiman DA. Esophageal contractility increases and gastroesophageal reflux does not worsen after lung transplantation. Dis Esophagus. 2019;32:1–8.PubMedCrossRef
13.
Zurück zum Zitat Wong D, Chan WW. Foregut dysmotility in the lung transplant patient. Curr Gastroenterol Rep. 2021;23:23.PubMedCrossRef Wong D, Chan WW. Foregut dysmotility in the lung transplant patient. Curr Gastroenterol Rep. 2021;23:23.PubMedCrossRef
14.
Zurück zum Zitat Murthy SC, Nowicki ER, Mason DP, Budev MM, Nunez AI, Thuita L, Chapman JT, McCurry KR, Pettersson GB, Blackstone EH. Pretransplant gastroesophageal reflux compromises early outcomes after lung transplantation. J Thorac Cardiovasc Surg. 2011;142:47-52.e43.PubMedCrossRef Murthy SC, Nowicki ER, Mason DP, Budev MM, Nunez AI, Thuita L, Chapman JT, McCurry KR, Pettersson GB, Blackstone EH. Pretransplant gastroesophageal reflux compromises early outcomes after lung transplantation. J Thorac Cardiovasc Surg. 2011;142:47-52.e43.PubMedCrossRef
15.
Zurück zum Zitat Shah N, Force SD, Mitchell PO, Lin E, Lawrence EC, Easley K, Qian J, Ramirez A, Neujahr DC, Gal A, Leeper K, Pelaez A. Gastroesophageal reflux disease is associated with an increased rate of acute rejection in lung transplant allografts. Transplant Proc. 2010;42:2702–6.PubMedPubMedCentralCrossRef Shah N, Force SD, Mitchell PO, Lin E, Lawrence EC, Easley K, Qian J, Ramirez A, Neujahr DC, Gal A, Leeper K, Pelaez A. Gastroesophageal reflux disease is associated with an increased rate of acute rejection in lung transplant allografts. Transplant Proc. 2010;42:2702–6.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Ciriza-de-los-Ríos C, Canga-Rodríguez-Valcárcel F, de-Pablo-Gafas A, Castel-de-Lucas I, Lora-Pablos D, Castellano-Tortajada G. Esophageal motor disorders are frequent during pre and post-lung transplantation. Can they influence lung rejection? Rev Esp Enferm Dig. 2018;110(6):344–51.PubMed Ciriza-de-los-Ríos C, Canga-Rodríguez-Valcárcel F, de-Pablo-Gafas A, Castel-de-Lucas I, Lora-Pablos D, Castellano-Tortajada G. Esophageal motor disorders are frequent during pre and post-lung transplantation. Can they influence lung rejection? Rev Esp Enferm Dig. 2018;110(6):344–51.PubMed
17.
Zurück zum Zitat Sun H, Deng M, Chen W, Liu M, Dai H, Wang C. Graft dysfunction and rejection of lung transplant, a review on diagnosis and management. Clin Respir J. 2022;16:5–12.PubMedPubMedCentralCrossRef Sun H, Deng M, Chen W, Liu M, Dai H, Wang C. Graft dysfunction and rejection of lung transplant, a review on diagnosis and management. Clin Respir J. 2022;16:5–12.PubMedPubMedCentralCrossRef
18.
19.
Zurück zum Zitat Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus G. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20 (quiz 1943).PubMedCrossRef Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus G. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20 (quiz 1943).PubMedCrossRef
20.
Zurück zum Zitat Sweet MP, Herbella FA, Leard L, Hoopes C, Golden J, Hays S, Patti MG. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann Surg. 2006;244:491–7.PubMedPubMedCentral Sweet MP, Herbella FA, Leard L, Hoopes C, Golden J, Hays S, Patti MG. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann Surg. 2006;244:491–7.PubMedPubMedCentral
21.
Zurück zum Zitat Lo WK, Burakoff R, Goldberg HJ, Feldman N, Chan WW. Pre-lung transplant measures of reflux on impedance are superior to pH testing alone in predicting early allograft injury. World J Gastroenterol. 2015;21:9111–7.PubMedPubMedCentralCrossRef Lo WK, Burakoff R, Goldberg HJ, Feldman N, Chan WW. Pre-lung transplant measures of reflux on impedance are superior to pH testing alone in predicting early allograft injury. World J Gastroenterol. 2015;21:9111–7.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Robertson AG, Ward C, Pearson JP, Small T, Lordan J, Fisher AJ, Bredenoord AJ, Dark J, Griffin SM, Corris PA. Longitudinal changes in gastro-oesophageal reflux from 3 months to 6 months after lung transplantation. Thorax. 2009;64:1005–7.PubMedCrossRef Robertson AG, Ward C, Pearson JP, Small T, Lordan J, Fisher AJ, Bredenoord AJ, Dark J, Griffin SM, Corris PA. Longitudinal changes in gastro-oesophageal reflux from 3 months to 6 months after lung transplantation. Thorax. 2009;64:1005–7.PubMedCrossRef
23.
Zurück zum Zitat D’Ovidio F, Mura M, Ridsdale R, Takahashi H, Waddell TK, Hutcheon M, Hadjiliadis D, Singer LG, Pierre A, Chaparro C, Gutierrez C, Miller L, Darling G, Liu M, Post M, Keshavjee S. The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D. Am J Transplant. 2006;6:1930–8.PubMedCrossRef D’Ovidio F, Mura M, Ridsdale R, Takahashi H, Waddell TK, Hutcheon M, Hadjiliadis D, Singer LG, Pierre A, Chaparro C, Gutierrez C, Miller L, Darling G, Liu M, Post M, Keshavjee S. The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D. Am J Transplant. 2006;6:1930–8.PubMedCrossRef
24.
Zurück zum Zitat Gouynou C, Philit F, Mion F, Tronc F, Sénéchal A, Giai J, Rabain AM, Mornex JF, Roman S. Esophageal motility disorders associated with death or allograft dysfunction after lung transplantation? Results of a retrospective monocentric study. Clin Transl Gastroenterol. 2020;11: e00137.PubMedPubMedCentralCrossRef Gouynou C, Philit F, Mion F, Tronc F, Sénéchal A, Giai J, Rabain AM, Mornex JF, Roman S. Esophageal motility disorders associated with death or allograft dysfunction after lung transplantation? Results of a retrospective monocentric study. Clin Transl Gastroenterol. 2020;11: e00137.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Masuda T, Mittal SK, Csucska M, Kovacs B, Walia R, Huang JL, Smith MA, Bremner RM. Esophageal aperistalsis and lung transplant: Recovery of peristalsis after transplant is associated with improved long-term outcomes. J Thorac Cardiovasc Surg. 2020;160:1613–26.PubMedCrossRef Masuda T, Mittal SK, Csucska M, Kovacs B, Walia R, Huang JL, Smith MA, Bremner RM. Esophageal aperistalsis and lung transplant: Recovery of peristalsis after transplant is associated with improved long-term outcomes. J Thorac Cardiovasc Surg. 2020;160:1613–26.PubMedCrossRef
26.
Zurück zum Zitat Hooft N, Smith M, Huang J, Bremner R, Walia R. Gastroparesis is common after lung transplantation and may be ameliorated by botulinum toxin-A injection of the pylorus. J Heart Lung Transplant. 2014;33:1314–6.PubMedCrossRef Hooft N, Smith M, Huang J, Bremner R, Walia R. Gastroparesis is common after lung transplantation and may be ameliorated by botulinum toxin-A injection of the pylorus. J Heart Lung Transplant. 2014;33:1314–6.PubMedCrossRef
27.
Zurück zum Zitat Raviv Y, D’Ovidio F, Pierre A, Chaparro C, Freeman M, Keshavjee S, Singer LG. Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes. Clin Transplant. 2012;26:133–42.PubMedCrossRef Raviv Y, D’Ovidio F, Pierre A, Chaparro C, Freeman M, Keshavjee S, Singer LG. Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes. Clin Transplant. 2012;26:133–42.PubMedCrossRef
28.
Zurück zum Zitat Derousseau T, Chan WW, Cangemi D, Kaza V, Lo WK, Gavini S. Delayed gastric emptying in prelung transplant patients is associated with posttransplant acute cellular rejection independent of reflux. J Clin Gastroenterol. 2022;56:e121–5.PubMedCrossRef Derousseau T, Chan WW, Cangemi D, Kaza V, Lo WK, Gavini S. Delayed gastric emptying in prelung transplant patients is associated with posttransplant acute cellular rejection independent of reflux. J Clin Gastroenterol. 2022;56:e121–5.PubMedCrossRef
29.
30.
Zurück zum Zitat Black RJ, Novakovic D, Plit M, Miles A, MacDonald P, Madill C. Swallowing and laryngeal complications in lung and heart transplantation: Etiologies and diagnosis. J Heart Lung Transplant. 2021;40:1483–94.PubMedCrossRef Black RJ, Novakovic D, Plit M, Miles A, MacDonald P, Madill C. Swallowing and laryngeal complications in lung and heart transplantation: Etiologies and diagnosis. J Heart Lung Transplant. 2021;40:1483–94.PubMedCrossRef
31.
Zurück zum Zitat Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal reflux disease: a review. JAMA. 2020;324:2536–47.PubMedCrossRef Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal reflux disease: a review. JAMA. 2020;324:2536–47.PubMedCrossRef
32.
Zurück zum Zitat Herregods TV, Bredenoord AJ, Smout AJ. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. Neurogastroenterol Motil. 2015;27:1202–13.PubMedCrossRef Herregods TV, Bredenoord AJ, Smout AJ. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. Neurogastroenterol Motil. 2015;27:1202–13.PubMedCrossRef
33.
Zurück zum Zitat Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, Vaezi M, Sifrim D, Fox MR, Vela MF, Tutuian R, Tack J, Bredenoord AJ, Pandolfino J, Roman S. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67:1351–62.PubMedCrossRef Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, Vaezi M, Sifrim D, Fox MR, Vela MF, Tutuian R, Tack J, Bredenoord AJ, Pandolfino J, Roman S. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67:1351–62.PubMedCrossRef
34.
Zurück zum Zitat Yadlapati R, DeLay K. Proton pump inhibitor-refractory gastroesophageal reflux disease. Med Clin N Am. 2019;103:15–27.PubMedCrossRef Yadlapati R, DeLay K. Proton pump inhibitor-refractory gastroesophageal reflux disease. Med Clin N Am. 2019;103:15–27.PubMedCrossRef
35.
Zurück zum Zitat Reid KR, McKenzie FN, Menkis AH, Novick RJ, Pflugfelder PW, Kostuk WJ, Ahmad D. Importance of chronic aspiration in recipients of heart-lung transplants. Lancet. 1990;336:206–8.PubMedCrossRef Reid KR, McKenzie FN, Menkis AH, Novick RJ, Pflugfelder PW, Kostuk WJ, Ahmad D. Importance of chronic aspiration in recipients of heart-lung transplants. Lancet. 1990;336:206–8.PubMedCrossRef
36.
Zurück zum Zitat Rinaldi M, Martinelli L, Volpato G, Pederzolli C, Silvestri M, Pederzolli N, Arbustini E, Vigano M. Gastro-esophageal reflux as cause of obliterative bronchiolitis: a case report. Transplant Proc. 1995;27:2006–7.PubMed Rinaldi M, Martinelli L, Volpato G, Pederzolli C, Silvestri M, Pederzolli N, Arbustini E, Vigano M. Gastro-esophageal reflux as cause of obliterative bronchiolitis: a case report. Transplant Proc. 1995;27:2006–7.PubMed
37.
Zurück zum Zitat Basseri B, Conklin JL, Pimentel M, Tabrizi R, Phillips EH, Simsir SA, Chaux GE, Falk JA, Ghandehari S, Soukiasian HJ. Esophageal motor dysfunction and gastroesophageal reflux are prevalent in lung transplant candidates. Ann Thorac Surg. 2010;90:1630–6.PubMedCrossRef Basseri B, Conklin JL, Pimentel M, Tabrizi R, Phillips EH, Simsir SA, Chaux GE, Falk JA, Ghandehari S, Soukiasian HJ. Esophageal motor dysfunction and gastroesophageal reflux are prevalent in lung transplant candidates. Ann Thorac Surg. 2010;90:1630–6.PubMedCrossRef
38.
Zurück zum Zitat Tangaroonsanti A, Lee AS, Crowell MD, Vela MF, Jones DR, Erasmus D, Keller C, Mallea J, Alvarez F, Almansa C, DeVault KR, Houghton LA. Impaired esophageal motility and clearance post-lung transplant: risk for chronic allograft failure. Clin Transl Gastroenterol. 2017;8: e102.PubMedPubMedCentralCrossRef Tangaroonsanti A, Lee AS, Crowell MD, Vela MF, Jones DR, Erasmus D, Keller C, Mallea J, Alvarez F, Almansa C, DeVault KR, Houghton LA. Impaired esophageal motility and clearance post-lung transplant: risk for chronic allograft failure. Clin Transl Gastroenterol. 2017;8: e102.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Snyder DL, Vela MF. Opioid-induced esophageal dysfunction. Curr Opin Gastroenterol. 2020;36:344–50.PubMedCrossRef Snyder DL, Vela MF. Opioid-induced esophageal dysfunction. Curr Opin Gastroenterol. 2020;36:344–50.PubMedCrossRef
40.
Zurück zum Zitat Ratuapli SK, Crowell MD, DiBaise JK, Vela MF, Ramirez FC, Burdick GE, Lacy BE, Murray JA. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110:979–84.PubMedCrossRef Ratuapli SK, Crowell MD, DiBaise JK, Vela MF, Ramirez FC, Burdick GE, Lacy BE, Murray JA. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110:979–84.PubMedCrossRef
41.
Zurück zum Zitat Ortiz V, Garcia-Campos M, Saez-Gonzalez E, delPozo P, Garrigues V. A concise review of opioid-induced esophageal dysfunction: is this a new clinical entity? Dis Esophagus. 2018;31:doy003.CrossRef Ortiz V, Garcia-Campos M, Saez-Gonzalez E, delPozo P, Garrigues V. A concise review of opioid-induced esophageal dysfunction: is this a new clinical entity? Dis Esophagus. 2018;31:doy003.CrossRef
42.
Zurück zum Zitat Snyder DL, Crowell MD, Horsley-Silva J, Ravi K, Lacy BE, Vela MF. Opioid-induced esophageal dysfunction: differential effects of type and dose. Am J Gastroenterol. 2019;114:1464–9.PubMedCrossRef Snyder DL, Crowell MD, Horsley-Silva J, Ravi K, Lacy BE, Vela MF. Opioid-induced esophageal dysfunction: differential effects of type and dose. Am J Gastroenterol. 2019;114:1464–9.PubMedCrossRef
43.
Zurück zum Zitat Woo M, Liu A, Wilsack L, Li D, Gupta M, Nasser Y, Buresi M, Curley M, Andrews CN. Gastroesophageal reflux disease is not associated with jackhammer esophagus: a case–control study. J Neurogastroenterol Motil. 2020;26:224–31.PubMedPubMedCentralCrossRef Woo M, Liu A, Wilsack L, Li D, Gupta M, Nasser Y, Buresi M, Curley M, Andrews CN. Gastroesophageal reflux disease is not associated with jackhammer esophagus: a case–control study. J Neurogastroenterol Motil. 2020;26:224–31.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Vanuytsel T, Bisschops R, Farre R, Pauwels A, Holvoet L, Arts J, Caenepeel P, De Wulf D, Mimidis K, Rommel N, Tack J. Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol. 2013;11:1115–21 (e1112).PubMedCrossRef Vanuytsel T, Bisschops R, Farre R, Pauwels A, Holvoet L, Arts J, Caenepeel P, De Wulf D, Mimidis K, Rommel N, Tack J. Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol. 2013;11:1115–21 (e1112).PubMedCrossRef
45.
Zurück zum Zitat Camilleri M, Lembo A, Katzka DA. Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits. Clin Gastroenterol Hepatol. 2017;15:1338–49.PubMedPubMedCentralCrossRef Camilleri M, Lembo A, Katzka DA. Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits. Clin Gastroenterol Hepatol. 2017;15:1338–49.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat van Hoeij FB, Tack JF, Pandolfino JE, Sternbach JM, Roman S, Smout AJ, Bredenoord AJ. Complications of botulinum toxin injections for treatment of esophageal motility disordersdagger. Dis Esophagus. 2017;30:1–5.PubMed van Hoeij FB, Tack JF, Pandolfino JE, Sternbach JM, Roman S, Smout AJ, Bredenoord AJ. Complications of botulinum toxin injections for treatment of esophageal motility disordersdagger. Dis Esophagus. 2017;30:1–5.PubMed
48.
Zurück zum Zitat Achem SR, Vazquez-Elizondo G, Fass R. Jackhammer esophagus: current concepts and dilemmas. J Clin Gastroenterol. 2021;55:369–79.PubMedCrossRef Achem SR, Vazquez-Elizondo G, Fass R. Jackhammer esophagus: current concepts and dilemmas. J Clin Gastroenterol. 2021;55:369–79.PubMedCrossRef
49.
Zurück zum Zitat Khan MQ, Nizami IY, Khan BJ, Al-Ashgar HI. Lung transplantation triggered “jackhammer esophagus”: a case report and review of literature. J Neurogastroenterol Motil. 2013;19:390–4.PubMedPubMedCentralCrossRef Khan MQ, Nizami IY, Khan BJ, Al-Ashgar HI. Lung transplantation triggered “jackhammer esophagus”: a case report and review of literature. J Neurogastroenterol Motil. 2013;19:390–4.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Herregods TV, Smout AJ, Ooi JL, Sifrim D, Bredenoord AJ. Jackhammer esophagus: observations on a European cohort. Neurogastroenterol Motil. 2017;29:e12975.CrossRef Herregods TV, Smout AJ, Ooi JL, Sifrim D, Bredenoord AJ. Jackhammer esophagus: observations on a European cohort. Neurogastroenterol Motil. 2017;29:e12975.CrossRef
51.
Zurück zum Zitat Jia Y, Arenas J, Hejazi RA, Elhanafi S, Saadi M, McCallum RW. Frequency of jackhammer esophagus as the extreme phenotypes of esophageal hypercontractility based on the new Chicago classification. J Clin Gastroenterol. 2016;50:615–8.PubMedCrossRef Jia Y, Arenas J, Hejazi RA, Elhanafi S, Saadi M, McCallum RW. Frequency of jackhammer esophagus as the extreme phenotypes of esophageal hypercontractility based on the new Chicago classification. J Clin Gastroenterol. 2016;50:615–8.PubMedCrossRef
52.
Zurück zum Zitat Sloan JA, Mulki R, Sandhu N, Samuel S, Katz PO. Jackhammer esophagus: symptom presentation, associated distal contractile integral, and assessment of bolus transit. J Clin Gastroenterol. 2019;53:295–7.PubMedCrossRef Sloan JA, Mulki R, Sandhu N, Samuel S, Katz PO. Jackhammer esophagus: symptom presentation, associated distal contractile integral, and assessment of bolus transit. J Clin Gastroenterol. 2019;53:295–7.PubMedCrossRef
53.
54.
Zurück zum Zitat Au J, Hawkins T, Venables C, Morritt G, Scott CD, Gascoigne AD, Corris PA, Hilton CJ, Dark JH. Upper gastrointestinal dysmotility in heart-lung transplant recipients. Ann Thorac Surg. 1993;55:94–7.PubMedCrossRef Au J, Hawkins T, Venables C, Morritt G, Scott CD, Gascoigne AD, Corris PA, Hilton CJ, Dark JH. Upper gastrointestinal dysmotility in heart-lung transplant recipients. Ann Thorac Surg. 1993;55:94–7.PubMedCrossRef
55.
Zurück zum Zitat Yadlapati R, Kahrilas PJ, Fox MR, Bredenoord AJ, Prakash Gyawali C, Roman S, Babaei A, Mittal RK, Rommel N, Savarino E, Sifrim D, Smout A, Vaezi MF, Zerbib F, Akiyama J, Bhatia S, Bor S, Carlson DA, Chen JW, Cisternas D, Cock C, Coss-Adame E, de Bortoli N, Defilippi C, Fass R, Ghoshal UC, Gonlachanvit S, Hani A, Hebbard GS, Wook Jung K, Katz P, Katzka DA, Khan A, Kohn GP, Lazarescu A, Lengliner J, Mittal SK, Omari T, Park MI, Penagini R, Pohl D, Richter JE, Serra J, Sweis R, Tack J, Tatum RP, Tutuian R, Vela MF, Wong RK, Wu JC, Xiao Y, Pandolfino JE. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0. Neurogastroenterol Motil. 2021;33:e14058.PubMedPubMedCentralCrossRef Yadlapati R, Kahrilas PJ, Fox MR, Bredenoord AJ, Prakash Gyawali C, Roman S, Babaei A, Mittal RK, Rommel N, Savarino E, Sifrim D, Smout A, Vaezi MF, Zerbib F, Akiyama J, Bhatia S, Bor S, Carlson DA, Chen JW, Cisternas D, Cock C, Coss-Adame E, de Bortoli N, Defilippi C, Fass R, Ghoshal UC, Gonlachanvit S, Hani A, Hebbard GS, Wook Jung K, Katz P, Katzka DA, Khan A, Kohn GP, Lazarescu A, Lengliner J, Mittal SK, Omari T, Park MI, Penagini R, Pohl D, Richter JE, Serra J, Sweis R, Tack J, Tatum RP, Tutuian R, Vela MF, Wong RK, Wu JC, Xiao Y, Pandolfino JE. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0. Neurogastroenterol Motil. 2021;33:e14058.PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat de Pablo A, Alonso R, Ciriza C, Lopez E, Canga F, Juarros L, Gamez P, Perez V. Gastroesophageal reflux and esophageal motility disorder after lung transplant: influence on the transplanted graft. Transplant Proc. 2021;53:1989–97.PubMedCrossRef de Pablo A, Alonso R, Ciriza C, Lopez E, Canga F, Juarros L, Gamez P, Perez V. Gastroesophageal reflux and esophageal motility disorder after lung transplant: influence on the transplanted graft. Transplant Proc. 2021;53:1989–97.PubMedCrossRef
57.
Zurück zum Zitat Csucska M, Razia D, Masuda T, Omar A, Giulini L, Smith MA, Walia R, Bremner RM, Mittal SK. Bilateral lung transplant for a connective tissue disorder: esophageal motility and 3-year survival. In Seminars in thoracic and cardiovascular surgery. 2021. Csucska M, Razia D, Masuda T, Omar A, Giulini L, Smith MA, Walia R, Bremner RM, Mittal SK. Bilateral lung transplant for a connective tissue disorder: esophageal motility and 3-year survival. In Seminars in thoracic and cardiovascular surgery. 2021.
58.
Zurück zum Zitat Gorodner MV, Galvani C, Fisichella PM, Patti MG. Preoperative lower esophageal sphincter pressure has little influence on the outcome of laparoscopic Heller myotomy for achalasia. Surg Endosc. 2004;18:774–8.PubMedCrossRef Gorodner MV, Galvani C, Fisichella PM, Patti MG. Preoperative lower esophageal sphincter pressure has little influence on the outcome of laparoscopic Heller myotomy for achalasia. Surg Endosc. 2004;18:774–8.PubMedCrossRef
60.
Zurück zum Zitat Millan MS, Bourdages R, Beck IT, DaCosta LR. Transition from diffuse esophageal spasm to achalasia. J Clin Gastroenterol. 1979;1:107–17.PubMedCrossRef Millan MS, Bourdages R, Beck IT, DaCosta LR. Transition from diffuse esophageal spasm to achalasia. J Clin Gastroenterol. 1979;1:107–17.PubMedCrossRef
61.
Zurück zum Zitat Longstreth GF, Foroozan P. Evolution of symptomatic diffuse esophageal spasm to achalasia. South Med J. 1982;75:217–20.PubMedCrossRef Longstreth GF, Foroozan P. Evolution of symptomatic diffuse esophageal spasm to achalasia. South Med J. 1982;75:217–20.PubMedCrossRef
62.
Zurück zum Zitat Usai Satta P, Oppia F, Piras R, Loriga F. Extrinsic autonomic neuropathy in a case of transition from diffuse esophageal spasm to achalasia. Clin Auton Res. 2004;14:270–2.PubMedCrossRef Usai Satta P, Oppia F, Piras R, Loriga F. Extrinsic autonomic neuropathy in a case of transition from diffuse esophageal spasm to achalasia. Clin Auton Res. 2004;14:270–2.PubMedCrossRef
63.
Zurück zum Zitat Anggiansah A, Bright NF, McCullagh M, Owen WJ. Transition from nutcracker esophagus to achalasia. Dig Dis Sci. 1990;35:1162–6.PubMedCrossRef Anggiansah A, Bright NF, McCullagh M, Owen WJ. Transition from nutcracker esophagus to achalasia. Dig Dis Sci. 1990;35:1162–6.PubMedCrossRef
64.
Zurück zum Zitat Paterson WG, Beck IT, Da Costa LR. Transition from nutcracker esophagus to achalasia. A case report. J Clin Gastroenterol. 1991;13:554–8.PubMedCrossRef Paterson WG, Beck IT, Da Costa LR. Transition from nutcracker esophagus to achalasia. A case report. J Clin Gastroenterol. 1991;13:554–8.PubMedCrossRef
65.
Zurück zum Zitat Khatami SS, Khandwala F, Shay SS, Vaezi MF. Does diffuse esophageal spasm progress to achalasia? A prospective cohort study. Dig Dis Sci. 2005;50:1605–10.PubMedCrossRef Khatami SS, Khandwala F, Shay SS, Vaezi MF. Does diffuse esophageal spasm progress to achalasia? A prospective cohort study. Dig Dis Sci. 2005;50:1605–10.PubMedCrossRef
66.
Zurück zum Zitat Fontes LH, Herbella FA, Rodriguez TN, Trivino T, Farah JF. Progression of diffuse esophageal spasm to achalasia: incidence and predictive factors. Dis Esophagus. 2013;26:470–4.PubMedCrossRef Fontes LH, Herbella FA, Rodriguez TN, Trivino T, Farah JF. Progression of diffuse esophageal spasm to achalasia: incidence and predictive factors. Dis Esophagus. 2013;26:470–4.PubMedCrossRef
67.
Zurück zum Zitat Eckardt VF. Clinical presentation and complications of achalasia. Gastrointest Endosc Clin N Am. 2001;11:281–92.PubMedCrossRef Eckardt VF. Clinical presentation and complications of achalasia. Gastrointest Endosc Clin N Am. 2001;11:281–92.PubMedCrossRef
68.
Zurück zum Zitat Schlottmann F, Patti MG. Esophageal achalasia: current diagnosis and treatment. Expert Rev Gastroenterol Hepatol. 2018;12:711–21.PubMedCrossRef Schlottmann F, Patti MG. Esophageal achalasia: current diagnosis and treatment. Expert Rev Gastroenterol Hepatol. 2018;12:711–21.PubMedCrossRef
69.
70.
Zurück zum Zitat Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB, Kavitt RT. ACG clinical guidelines: diagnosis and management of achalasia. Am J Gastroenterol. 2020;115:1393–411.PubMedPubMedCentralCrossRef Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB, Kavitt RT. ACG clinical guidelines: diagnosis and management of achalasia. Am J Gastroenterol. 2020;115:1393–411.PubMedPubMedCentralCrossRef
71.
Zurück zum Zitat Zikos TA, Triadafilopoulos G, Clarke JO. Esophagogastric junction outflow obstruction: current approach to diagnosis and management. Curr Gastroenterol Rep. 2020;22:9.PubMedCrossRef Zikos TA, Triadafilopoulos G, Clarke JO. Esophagogastric junction outflow obstruction: current approach to diagnosis and management. Curr Gastroenterol Rep. 2020;22:9.PubMedCrossRef
72.
Zurück zum Zitat Samo S, Qayed E. Esophagogastric junction outflow obstruction: where are we now in diagnosis and management? World J Gastroenterol. 2019;25:411–7.PubMedPubMedCentralCrossRef Samo S, Qayed E. Esophagogastric junction outflow obstruction: where are we now in diagnosis and management? World J Gastroenterol. 2019;25:411–7.PubMedPubMedCentralCrossRef
73.
Zurück zum Zitat Blonski W, Kumar A, Feldman J, Richter JE. Timed barium swallow: diagnostic role and predictive value in untreated achalasia, esophagogastric junction outflow obstruction, and non-achalasia dysphagia. Am J Gastroenterol. 2018;113:196–203.PubMedCrossRef Blonski W, Kumar A, Feldman J, Richter JE. Timed barium swallow: diagnostic role and predictive value in untreated achalasia, esophagogastric junction outflow obstruction, and non-achalasia dysphagia. Am J Gastroenterol. 2018;113:196–203.PubMedCrossRef
74.
Zurück zum Zitat Fox MR, Sweis R, Yadlapati R, Pandolfino J, Hani A, Defilippi C, Jan T, Rommel N. Chicago classification version 4.0((c)) technical review: Update on standard high-resolution manometry protocol for the assessment of esophageal motility. Neurogastroenterol Motil. 2021;33:e14120.PubMedPubMedCentralCrossRef Fox MR, Sweis R, Yadlapati R, Pandolfino J, Hani A, Defilippi C, Jan T, Rommel N. Chicago classification version 4.0((c)) technical review: Update on standard high-resolution manometry protocol for the assessment of esophageal motility. Neurogastroenterol Motil. 2021;33:e14120.PubMedPubMedCentralCrossRef
75.
Zurück zum Zitat Griffin SM, Robertson AG, Bredenoord AJ, Brownlee IA, Stovold R, Brodlie M, Forrest I, Dark JH, Pearson JP, Ward C. Aspiration and allograft injury secondary to gastroesophageal reflux occur in the immediate post-lung transplantation period (prospective clinical trial). Ann Surg. 2013;258:705–11 (discussion 711–702).PubMedCrossRef Griffin SM, Robertson AG, Bredenoord AJ, Brownlee IA, Stovold R, Brodlie M, Forrest I, Dark JH, Pearson JP, Ward C. Aspiration and allograft injury secondary to gastroesophageal reflux occur in the immediate post-lung transplantation period (prospective clinical trial). Ann Surg. 2013;258:705–11 (discussion 711–702).PubMedCrossRef
76.
Zurück zum Zitat Davis CS, Shankaran V, Kovacs EJ, Gagermeier J, Dilling D, Alex CG, Love RB, Sinacore J, Fisichella PM. Gastroesophageal reflux disease after lung transplantation: pathophysiology and implications for treatment. Surgery. 2010;148:737–44 (discussion 744–735).PubMedCrossRef Davis CS, Shankaran V, Kovacs EJ, Gagermeier J, Dilling D, Alex CG, Love RB, Sinacore J, Fisichella PM. Gastroesophageal reflux disease after lung transplantation: pathophysiology and implications for treatment. Surgery. 2010;148:737–44 (discussion 744–735).PubMedCrossRef
Metadaten
Titel
Esophageal Dysfunction in Post-lung Transplant: An Enigma
verfasst von
Aditya V. Jadcherla
Kevin Litzenberg
Gokulakrishnan Balasubramanian
Publikationsdatum
12.08.2022
Verlag
Springer US
Erschienen in
Dysphagia / Ausgabe 3/2023
Print ISSN: 0179-051X
Elektronische ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-022-10508-3

Weitere Artikel der Ausgabe 3/2023

Dysphagia 3/2023 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.